Pfizer Stock Looks Undervalued: Is a 30% Rally Coming?
Pfizer (NYSE: PFE) is trading at just 9 times earnings with a 6% yield, and analysts see up to 30% upside. Is the market underestimating its cash flow, dividend strength, and global scale? I break down the numbers and reveal why this defensive giant could quietly surprise investors in 2026. Stock prices used were the … Read more
